Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Vepdegestrant	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Vepdegestrant Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Vibostolimab	TIGIT Inhibitor	Solid Tumour
Molecule Vibostolimab Therapeutic Category Immunotherapy (Investigational Checkpoint) Oncology Type Solid Tumour Drug Class / Mechanism TIGIT Inhibitor
Vobramitamab Duocarmazine	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Vobramitamab Duocarmazine Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Volrustomig	Bispecific Checkpoint Antibody, PD-1 x CTLA-4	Solid Tumour
Molecule Volrustomig Therapeutic Category Immunotherapy (Investigational Checkpoint) Oncology Type Solid Tumour Drug Class / Mechanism Bispecific Checkpoint Antibody, PD-1 x CTLA-4
Vopratelimab	Costimulatory / Bispecific Agent	Solid Tumour
Molecule Vopratelimab Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Vusolimogene	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Vusolimogene Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Vusolimogene Oderparepvec	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Vusolimogene Oderparepvec Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Zenocutuzumab	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Zenocutuzumab Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Zoldonrasib	RAS(ON) G12D-Selective Tri-Complex Inhibitor	Solid Tumour
Molecule Zoldonrasib Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism RAS(ON) G12D-Selective Tri-Complex Inhibitor
Zongertinib	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Zongertinib Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent

Vepdegestrant Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Vibostolimab Immunotherapy (Investigational Checkpoint)
Therapeutic Category Immunotherapy (Investigational Checkpoint) Oncology Type Solid Tumour Drug Class / Mechanism TIGIT Inhibitor
Vobramitamab Duocarmazine Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Volrustomig Immunotherapy (Investigational Checkpoint)
Therapeutic Category Immunotherapy (Investigational Checkpoint) Oncology Type Solid Tumour Drug Class / Mechanism Bispecific Checkpoint Antibody, PD-1 x CTLA-4
Vopratelimab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Vusolimogene Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Vusolimogene Oderparepvec Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Zenocutuzumab Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Zoldonrasib Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism RAS(ON) G12D-Selective Tri-Complex Inhibitor
Zongertinib Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent

‹ 1 … 27 28 29 ›

Product Range

Company

Global Network

Products

All Products (346)

Vepdegestrant

Vibostolimab

Vobramitamab Duocarmazine

Volrustomig

Vopratelimab

Vusolimogene

Vusolimogene Oderparepvec

Zenocutuzumab

Zoldonrasib

Zongertinib

Vepdegestrant

Vibostolimab

Vobramitamab Duocarmazine

Volrustomig

Vopratelimab

Vusolimogene

Vusolimogene Oderparepvec

Zenocutuzumab

Zoldonrasib

Zongertinib